Apollo Endosurgery, Inc. | TalkMarkets | Page 1
No data available
No data available

People who follow this stock (9)

Latest Posts

About This Stock More About This Stock
Apollo Endosurgery Upgraded To Overweight From Neutral At Piper Sandler
Article By: The Fly
Monday, November 30, 2020 5:12 AM EDT
Piper Sandler analyst Adam Maeder upgraded Apollo Endosurgery to Overweight from Neutral with a price target of $5, up from $2.
In this article: APEN

Latest Tweets for $APEN

No tweets yet!